H Lundbeck A/S Company Profile (OTC:HLUYY)

About H Lundbeck A/S (OTC:HLUYY)

H Lundbeck A/S logoH Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer's disease, Bipolar disorder, depression, epilepsy, Huntington's disease, Parkinson's disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer's disease, Azilect for the treatment of Parkinson's disease, Xenazine for the treatment of Huntington's disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTC:HLUYY
  • CUSIP: N/A
  • Web: www.lundbeck.com
  • Market Cap: $11.92 billion
  • Outstanding Shares: 197,300,000
Average Prices:
  • 50 Day Moving Avg: $55.70
  • 200 Day Moving Avg: $48.12
  • 52 Week Range: $31.00 - $60.78
  • Trailing P/E Ratio: 48.19
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $2.47 billion
  • Price / Sales: 4.83
  • Book Value: $7.64 per share
  • Price / Book: 7.91
  • EBIDTA: $629.13 million
  • Net Margins: 9.96%
  • Return on Equity: 27.04%
  • Return on Assets: 12.49%
  • Debt-to-Equity Ratio: 0.17%
  • Current Ratio: 1.07%
  • Quick Ratio: 0.81%
  • Average Volume: 7,041 shs.
  • Beta: 0.32
Frequently Asked Questions for H Lundbeck A/S (OTC:HLUYY)

What is H Lundbeck A/S's stock symbol?

H Lundbeck A/S trades on the OTC under the ticker symbol "HLUYY."

Who are some of H Lundbeck A/S's key competitors?

Who are H Lundbeck A/S's key executives?

H Lundbeck A/S's management team includes the folowing people:

  • Lars Rasmussen, Independent Chairman of the Board
  • Kaare Schultz, President, Chief Executive Officer
  • Lene Skole, Deputy Chairman of the Board
  • Anders Goetzsche, Chief Financial Officer, Executive Vice President
  • Staffan Schueberg, Executive Vice President, Chief Commercial Officer
  • Lars Bang, Executive Vice President, Supply Operations & Engineering
  • Anders Gersel Pedersen M.D., Ph.D., Executive Vice President, Research and Development
  • Jacob Tolstrup, Executive Vice President, Corporate Functions
  • Mona Elisabeth Elster, Director, Employee Representative
  • Lars Holmqvist, Director

How do I buy H Lundbeck A/S stock?

Shares of H Lundbeck A/S can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is H Lundbeck A/S's stock price today?

One share of H Lundbeck A/S stock can currently be purchased for approximately $60.43.

MarketBeat Community Rating for H Lundbeck A/S (OTC HLUYY)
Community Ranking:  1.9 out of 5 ()
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  8
MarketBeat's community ratings are surveys of what our community members think about H Lundbeck A/S and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for H Lundbeck A/S (OTC:HLUYY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for H Lundbeck A/S (OTC:HLUYY)
DateFirmActionRatingPrice TargetDetails
4/12/2017Jefferies Group LLCDowngradeBuy -> HoldView Rating Details
(Data available from 7/23/2015 forward)


Earnings History for H Lundbeck A/S (OTC:HLUYY)
No earnings announcements for this company have been tracked by MarketBeat.com


Earnings Estimates for H Lundbeck A/S (OTC:HLUYY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171$0.52$0.52$0.52
Q3 20171$0.53$0.53$0.53
Q4 20171$0.59$0.59$0.59
(Data provided by Zacks Investment Research)


Dividend History for H Lundbeck A/S (OTC:HLUYY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for H Lundbeck A/S (OTC:HLUYY)
No insider trades for this company have been tracked by MarketBeat.com


Headline Trends for H Lundbeck A/S (OTC:HLUYY)
Latest Headlines for H Lundbeck A/S (OTC:HLUYY)


This page was last updated on 7/23/2017 by MarketBeat.com Staff